Mechanism of action of nadofaragene firadenovec-vncg.

Autor: Narayan VM; Department of Urology, Emory University, Atlanta, GA, United States., Meeks JJ; Department of Urology, Northwestern University, Chicago, IL, United States., Jakobsen JS; Ferring Pharmaceuticals, International PharmaScience Center, Copenhagen, Denmark., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, United States., Sant GR; Department of Urology, Tufts University School of Medicine, Boston, MA, United States., Konety BR; Allina Health Cancer Institute, Minneapolis, MN, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Mar 15; Vol. 14, pp. 1359725. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.

Autor: Tutrone R; Chesapeake Urology Research Associates, Baltimore, MD, USA. rtutrone@uniteduro.com., Lowentritt B; Chesapeake Urology Research Associates, Baltimore, MD, USA., Neuman B; Chesapeake Urology Research Associates, Baltimore, MD, USA., Donovan MJ; Icahn School of Medicine at Mt. Sinai, New York City, NY, USA., Hallmark E; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Cole TJ; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Yao Y; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Biesecker C; Chesapeake Urology Research Associates, Baltimore, MD, USA., Kumar S; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Verma V; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Sant GR; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA.; Department of Urology, Tufts University, Medford, MA, USA., Alter J; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA., Skog J; Exosome Diagnostics, a Bio-Techne Brand, Waltham, MA, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Sep; Vol. 26 (3), pp. 596-601. Date of Electronic Publication: 2023 May 16.

How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary care.

Autor: Moul JW; Division of Urologic Surgery, Duke University Medical Center, Durham, North Carolina, USA., Sant GR; Department of Urology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Publikováno v: The Canadian journal of urology [Can J Urol] 2022 Aug; Vol. 29 (4), pp. 11224-11230.

SuperGAG biopolymers for treatment of excessive bladder permeability.

Autor: Towner RA; Oklahoma Center for Neuroscience, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA.; Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.; Department of Pathology, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Greenwood-Van Meerveld B; Oklahoma Center for Neuroscience, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA.; Department of Physiology, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Mohammadi E; Oklahoma Center for Neuroscience, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Saunders D; Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Smith N; Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Sant GR; Department of Urology, Tufts University School of Medicine, Boston, MA, USA., Shain HC; Glycologix, LLC, Beverly, MA, USA., Jozefiak TH; Glycologix, LLC, Beverly, MA, USA., Hurst RE; Glycologix, LLC, Beverly, MA, USA.

Publikováno v: Pharmacology research & perspectives [Pharmacol Res Perspect] 2021 Feb; Vol. 9 (1), pp. e00709.

Joint Terminology Report: Terminology Standardization for Female Bladder Pain Syndrome.

Publikováno v: Urogynecology (Philadelphia, Pa.) [Urogynecology (Phila)] 2025 Jan 06. Date of Electronic Publication: 2025 Jan 06.